3SQ1 Fundamental Analysis - AHT SYNGAS TECHNOLOGY NV

Fundamental Rating

3SQ1 gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 43 industry peers in the Construction & Engineering industry. Both the profitability and financial health of 3SQ1 have multiple concerns. 3SQ1 is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year 3SQ1 has reported negative net income.
The reported net income has been mixed in the past 5 years: 3SQ1 reported negative net income in multiple years.
3SQ1 had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of 3SQ1 (-22.27%) is worse than 97.67% of its industry peers.
3SQ1's Return On Equity of -53.96% is on the low side compared to the rest of the industry. 3SQ1 is outperformed by 95.35% of its industry peers.

		Industry Rank	Sector Rank
ROA	-22.27%
ROE	-53.96%
ROIC	N/A

ROA(3y)-8.05%

ROA(5y)-6.53%

ROE(3y)-16.29%

ROE(5y)-12.08%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for 3SQ1 so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

3SQ1 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 3SQ1 has more shares outstanding
Compared to 1 year ago, 3SQ1 has an improved debt to assets ratio.

2.2 Solvency

3SQ1 has an Altman-Z score of 0.18. This is a bad value and indicates that 3SQ1 is not financially healthy and even has some risk of bankruptcy.
3SQ1 has a worse Altman-Z score (0.18) than 95.35% of its industry peers.
3SQ1 has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
3SQ1 has a better Debt to Equity ratio (0.04) than 95.35% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	0.18

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

3SQ1 has a Current Ratio of 1.49. This is a normal value and indicates that 3SQ1 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.49, 3SQ1 is in the better half of the industry, outperforming 79.07% of the companies in the same industry.
3SQ1 has a Quick Ratio of 1.27. This is a normal value and indicates that 3SQ1 is financially healthy and should not expect problems in meeting its short term obligations.
3SQ1 has a better Quick ratio (1.27) than 76.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.49
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for 3SQ1 have decreased strongly by -381.25% in the last year.
3SQ1 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.64%.
The Revenue has been growing by 52.65% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-381.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-722.22%

Revenue 1Y (TTM)-30.64%

Revenue growth 3Y115.36%

Revenue growth 5Y52.65%

Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, 3SQ1 will show a very strong growth in Earnings Per Share. The EPS will grow by 45.22% on average per year.
3SQ1 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 53.24% yearly.

EPS Next Y74.49%

EPS Next 2Y43.92%

EPS Next 3Y41.9%

EPS Next 5Y45.22%

Revenue Next Year-14.23%

Revenue Next 2Y18.16%

Revenue Next 3Y39.66%

Revenue Next 5Y53.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 3SQ1. In the last year negative earnings were reported.
Also next year 3SQ1 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

3SQ1's earnings are expected to grow with 41.90% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y43.92%

EPS Next 3Y41.9%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

3SQ1 does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

AHT SYNGAS TECHNOLOGY NV

FRA:3SQ1 (1/20/2026, 7:00:00 PM)

4.06

+0.38 (+10.33%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryConstruction & Engineering

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners11.88%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap10.15M

Revenue(TTM)9.47M

Net Income(TTM)-2.45M

Analysts84

Price Target19.47 (379.56%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-4.41%

PT rev (3m)-8.38%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.07
P/FCF	N/A
P/OCF	N/A
P/B	2.41
P/tB	2.64
EV/EBITDA	N/A

EPS(TTM)-0.9

EYN/A

EPS(NY)-0.25

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS3.79

BVpS1.69

TBVpS1.54

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-22.27%
ROE	-53.96%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-8.05%

ROA(5y)-6.53%

ROE(3y)-16.29%

ROE(5y)-12.08%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.86

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.49
Quick Ratio	1.27
Altman-Z	0.18

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-381.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-722.22%

EPS Next Y74.49%

EPS Next 2Y43.92%

EPS Next 3Y41.9%

EPS Next 5Y45.22%

Revenue 1Y (TTM)-30.64%

Revenue growth 3Y115.36%

Revenue growth 5Y52.65%

Sales Q2Q%-100%

Revenue Next Year-14.23%

Revenue Next 2Y18.16%

Revenue Next 3Y39.66%

Revenue Next 5Y53.24%

EBIT growth 1Y-361.9%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.31%

EBIT Next 3Y45.6%

EBIT Next 5Y47.06%

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

AHT SYNGAS TECHNOLOGY NV / 3SQ1.DE FAQ

What is the ChartMill fundamental rating of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to 3SQ1.DE.

What is the valuation status for 3SQ1 stock?

ChartMill assigns a valuation rating of 1 / 10 to AHT SYNGAS TECHNOLOGY NV (3SQ1.DE). This can be considered as Overvalued.

What is the profitability of 3SQ1 stock?

AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) has a profitability rating of 0 / 10.

How financially healthy is AHT SYNGAS TECHNOLOGY NV?

The financial health rating of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) is 3 / 10.

AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AHT SYNGAS TECHNOLOGY NV / 3SQ1.DE FAQ

What is the ChartMill fundamental rating of AHT SYNGAS TECHNOLOGY NV (3SQ1.DE) stock?

What is the valuation status for 3SQ1 stock?

What is the profitability of 3SQ1 stock?

How financially healthy is AHT SYNGAS TECHNOLOGY NV?